Author

Jing Yang

Houston Methodist Research Institute - Cited by 5,494 - multiple myeloma - tumor microenvironment - tumor metabolism - adipocytes - tumor bone disease and immunotherapy

Biography

Jing Yang is a Professor at Cancer Research Institution, Guangzhou Medical University, Guangzhou, China. Houston Methodist Research Institute Verified email at houstonmethodist.org multiple myelomatumor microenvironmenttumor metabolismadipocytestumor bone disease and imm
Title
Cited by
Year
FGF/FGFR signaling in health and disease
Y Xie, N Su, J Yang, Q Tan, S Huang, M Jin, Z Ni, B Zhang, D Zhang, ...Signal transduction and targeted therapy 5 (1), 181, 2020202
318
2020
Mature adipocytes in bone marrow protect myeloma cells against chemotherapy through autophagy activation
Z Liu, J Xu, J He, H Liu, P Lin, X Wan, NM Navone, Q Tong, LW Kwak, ...Oncotarget 6 (33), 34329, 2015201
123
2015
A critical role of autocrine sonic hedgehog signaling in human CD138+ myeloma cell survival and drug resistance
Z Liu, J Xu, J He, Y Zheng, H Li, Y Lu, J Qian, P Lin, DM Weber, J Yang, ...Blood, The Journal of the American Society of Hematology 124 (13), 2061-2071, 2014201
95
2014
Tight junction protein 1 modulates proteasome capacity and proteasome inhibitor sensitivity in multiple myeloma via EGFR/JAK1/STAT3 signaling
XD Zhang, V Baladandayuthapani, H Lin, G Mulligan, B Li, DLW Esseltine, ...Cancer cell 29 (5), 639-652, 2016201
94
2016
Bone function, dysfunction and its role in diseases including critical illness
N Su, J Yang, Y Xie, X Du, H Chen, H Zhou, L ChenInternational journal of biological sciences 15 (4), 776, 2019201
88
2019
MicroRNA-451 regulates stemness of side population cells via PI3K/Akt/mTOR signaling pathway in multiple myeloma
J Du, S Liu, J He, X Liu, Y Qu, W Yan, J Fan, R Li, H Xi, W Fu, C Zhang, ...Oncotarget 6 (17), 14993, 2015201
86
2015
p38 MAPK inhibits breast cancer metastasis through regulation of stromal expansion
B Hong, H Li, M Zhang, J Xu, Y Lu, Y Zheng, J Qian, JT Chang, J Yang, ...International journal of cancer 136 (1), 34-43, 2015201
63
2015
Reprogrammed marrow adipocytes contribute to myeloma-induced bone disease
H Liu, J He, SP Koh, Y Zhong, Z Liu, Z Wang, Y Zhang, Z Li, BT Tam, P Lin, ...Science translational medicine 11 (494), eaau9087, 2019201
60
2019
RNA Polymerase I Inhibition with CX‐5461 as a Novel Therapeutic Strategy to Target MYC in Multiple Myeloma
HC Lee, H Wang, V Baladandayuthapani, H Lin, J He, RJ Jones, I Kuiatse, ...British journal of haematology 177 (1), 80-94, 2017201
59
2017
Thymidine phosphorylase exerts complex effects on bone resorption and formation in myeloma
H Liu, Z Liu, J Du, J He, P Lin, B Amini, MW Starbuck, N Novane, JJ Shah, ...Science translational medicine 8 (353), 353ra113-353ra113, 2016201
56
2016
p38 MAPK-inhibited dendritic cells induce superior antitumour immune responses and overcome regulatory T-cell-mediated immunosuppression
Y Lu, M Zhang, S Wang, B Hong, Z Wang, H Li, Y Zheng, J Yang, ...Nature communications 5 (1), 4229, 2014201
56
2014
Chondrocyte FGFR3 regulates bone mass by inhibiting osteogenesis
X Wen, X Li, Y Tang, J Tang, S Zhou, Y Xie, J Guo, J Yang, X Du, N Su, ...Journal of Biological Chemistry 291 (48), 24912-24921, 2016201
50
2016
Acetyl-CoA synthetase 2: a critical linkage in obesity-induced tumorigenesis in myeloma
Z Li, H Liu, J He, Z Wang, Z Yin, G You, Z Wang, RE Davis, P Lin, ...Cell metabolism 33 (1), 78-93. e7, 2021202
44
2021
Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy
J Park, H Li, M Zhang, Y Lu, B Hong, Y Zheng, J He, J Yang, J Qian, Q YiCancer Immunology, Immunotherapy 63, 835-845, 2014201
43
2014
Induction of m6A methylation in adipocyte exosomal LncRNAs mediates myeloma drug resistance
Z Wang, J He, D Bach, Y Huang, Z Li, H Liu, P Lin, J YangJournal of Experimental & Clinical Cancer Research , 1-18, 2022202
41
2022
Role of myeloma-derived MIF in myeloma cell adhesion to bone marrow and chemotherapy response
Y Zheng, Q Wang, T Li, J Qian, Y Lu, Y Li, E Bi, F Reu, Y Qin, J Drazba, ...Journal of the National Cancer Institute 108 (11), djw131, 2016201
40
2016
Resistin induces multidrug resistance in myeloma by inhibiting cell death and upregulating ABC transporter expression
J Pang, Q Shi, Z Liu, J He, H Liu, P Lin, J Cui, J YangHaematologica 102 (7), 1273, 2017201
36
2017
FGFR3 deficiency enhances CXCL12-dependent chemotaxis of macrophages via upregulating CXCR7 and aggravates joint destruction in mice
L Kuang, J Wu, N Su, H Qi, H Chen, S Zhou, Y Xiong, X Du, Q Tan, J Yang, ...Annals of the Rheumatic Diseases 79 (1), 112-122, 2020202
34
2020
Universal SLAMF7-specific CAR T-cells as treatment for multiple myeloma
R Mathur, Z Zhang, J He, R Galetto, A Gouble, I Chion-Sotinel, S Filipe, ...Blood 130, 502, 2017201
32
2017
MAPK11 in breast cancer cells enhances osteoclastogenesis and bone resorption
Z He, J He, Z Liu, J Xu, FY Sofia, H Liu, J YangBiochimie 106, 24-32, 2014201
31
2014

Referred From: https://scholar.google.com/citations?hl=en&user=jTteLbIAAAAJ

Cited by
Citations 5494
h-index 43
i10-index 78
Recommended Journals
Open Access Journals